Compounds that prevent homodimerization or result in the degradation of BCL6 (Kerres et al., 2017 ▸) have been shown to have highly effective cytotoxic activity in B-cell lymphomas. Here, BCL6 is linked to B-cell non-Hodgkin lymphoma.